brand logo

Am Fam Physician. 2001;63(2):219

to the editor: In the article on mitral valve prolapse (MVP),1 I thought it was great that the authors mentioned the significance of the “subclinical” disorder of “mitral valve prolapse syndrome,” in which 2 percent of the population with MVP are symptomatic during a given year. They stated that “reassurance is the major task of management because most patients with MVP are asymptomatic and not at high risk.” I believe it is critical, however, that patients who are symptomatic also receive the same reassurance, because the symptoms—especially the chest pain and tachycardia—often feel life-threatening to the patient.

Furthermore, I believe the authors too easily brushed off the association of MVP with panic disorder as being a chance occurrence. Many times, a person's panic disorder is started by MVP symptoms that seem to hit “out of the blue,” resulting in a whole series of unfortunate associations that begin a vicious circle of panic and anxiety attacks, ultimately leading to frequent emergency department visits. Treating the anxiety and panic that is often associated with MVP is critical.

In addition, a subpopulation of the 2 percent of symptomatic patients with MVP develop some level of depression (which was at one time called a “neurotic depression”). This may, in part, be precipitated by the patient's long-standing symptoms. These patients are often concerned that they are dying or that something is seriously wrong. These patients go from doctor to doctor and are not diagnosed or treated properly. Both of these subpopulations of the 2 percent of the symptomatic patients respond well to the proper care and concern from their family physician and a couple of visits with a behavioral medicine subspecialist or health psychologist. Often, they require beta-blocker or psychotropic therapy for a short time while they make the necessary lifestyle changes mentioned in the article. I hope that future authors are encouraged by the editors to not miss the relevant aspects of behavioral medicine.

editor's note: This letter was sent to the authors of “Current Management of Mitral Valve Prolapse,” who declined to reply.

Email letter submissions to afplet@aafp.org. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors. Letters submitted for publication in AFP must not be submitted to any other publication. Letters may be edited to meet style and space requirements.

This series is coordinated by Kenny Lin, MD, MPH, deputy editor.

Continue Reading


More in AFP

Copyright © 2001 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.